I'm one of many earlier folks to arrive here in Chicago. All everyone is talking about is immunotherapy, with Provenge/DNDN pretty much coming up in every conversation. This is gonna be talked about all weekend long and should be the star of ASCO.
I can and corroborate this notion...weekend ASCO talk is ALL immunotherapy, with a heavy "dose" of provenge/DNDN. It's definitely getting all the headlines here. I wouldn't be shocked to see a major pop on Monday right after the conference wraps up, and likely an upward trend in the next few weeks.